Mapping crossover events of mouse meiotic recombination by restriction fragment ligation-based Refresh-seq.
Yan WangYijun ChenJunpeng GaoHaoling XieYuqing GuoJingwei YangJun'e LiuZonggui ChenQingqing LiMengyao LiJie RenLu WenFu-Chou TangPublished in: Cell discovery (2024)
Single-cell whole-genome sequencing methods have undergone great improvements over the past decade. However, allele dropout, which means the inability to detect both alleles simultaneously in an individual diploid cell, largely restricts the application of these methods particularly for medical applications. Here, we develop a new single-cell whole-genome sequencing method based on third-generation sequencing (TGS) platform named Refresh-seq (restriction fragment ligation-based genome amplification and TGS). It is based on restriction endonuclease cutting and ligation strategy in which two alleles in an individual cell can be cut into equal fragments and tend to be amplified simultaneously. As a new single-cell long-read genome sequencing method, Refresh-seq features much lower allele dropout rate compared with SMOOTH-seq. Furthermore, we apply Refresh-seq to 688 sperm cells and 272 female haploid cells (secondary polar bodies and parthenogenetic oocytes) from F1 hybrid mice. We acquire high-resolution genetic map of mouse meiosis recombination at low sequencing depth and reveal the sexual dimorphism in meiotic crossovers. We also phase the structure variations (deletions and insertions) in sperm cells and female haploid cells with high precision. Refresh-seq shows great performance in screening aneuploid sperm cells and oocytes due to the low allele dropout rate and has great potential for medical applications such as preimplantation genetic diagnosis.
Keyphrases
- single cell
- rna seq
- induced apoptosis
- genome wide
- high throughput
- cell cycle arrest
- high resolution
- healthcare
- oxidative stress
- dna repair
- randomized controlled trial
- signaling pathway
- mental health
- dna damage
- metabolic syndrome
- endoplasmic reticulum stress
- clinical trial
- risk assessment
- dna methylation
- open label
- optical coherence tomography
- insulin resistance
- single molecule
- study protocol
- liquid chromatography
- double blind